Mutations and Polymorphisms in the Human Argininosuccinate Synthetase (ASS1) Gene

被引:75
作者
Engel, Katharina [1 ]
Hoehne, Wolfgang [2 ]
Haeberle, Johannes [1 ]
机构
[1] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed, D-48149 Munster, Germany
[2] Charite Univ Med Berlin, Inst Biochem, D-13353 Berlin, Germany
关键词
ASS1; ASS; argininosuccinate synthetase; citrullinemia; urea cycle; hyperammonemia; inborn error of metabolism; inherited metabolic disorder; CLASSICAL CITRULLINEMIA; PRENATAL-DIAGNOSIS; MESSENGER-RNA; MILD CITRULLINEMIA; DEFICIENCY; PHENOTYPE; HETEROGENEITY; LOCUS; CDNA;
D O I
10.1002/humu.20847
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Citrullinemia type I is an autosomal recessive disorder that is caused by a deficiency of the urea cycle enzyme argininosuccinate synthetase (ASS1). Deficiency of ASS1 shows various clinical manifestations encompassing severely affected patients with fatal neonatal hyperammonemia as well as asymptomatic individuals with only a biochemical phenotype. This is a comprehensive report of all 87 mutations found to date in the ASS1 gene on chromosome 9q34.1. A large proportion of the mutations (n = 27) are described here for the first time. Mutations are distributed throughout exons 3 to 15, most of them being identified in exons 5, 12, 13, and 14. The mutation G390R in exon 15 is the single most common mutation in patients with the classical phenotype. Certain mutations clearly link to specific clinical courses but the clinical phenotype cannot be anticipated in all patients. This update presents a survey of the correlation between mutations in the ASS1 gene and the respective clinical courses as described so far. It also sheds light on the geographic incidence of the mutations. Enzymatic studies have been done in bacterial and human cell systems. However, the prognostic value of genetic aberrations with respect to their effect on protein function and clinical manifestation remains uncertain. Hum Mutat 30, 300-307, 2009. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:300 / 307
页数:8
相关论文
共 36 条
[21]   PRENATAL-DIAGNOSIS OF CITRULLINEMIA - ELEVATED LEVELS OF CITRULLINE IN THE AMNIOTIC-FLUID IN THE 3 AFFECTED PREGNANCIES [J].
KLEIJER, WJ ;
BLOM, W ;
HUIJMANS, JGM ;
MOOYMAN, MCT ;
BERGER, R ;
NIERMEIJER, MF .
PRENATAL DIAGNOSIS, 1984, 4 (02) :113-118
[22]  
KOBAYASHI K, 1994, AM J HUM GENET, V55, P1103
[23]  
KOBAYASHI K, 1995, HUM GENET, V96, P454
[24]  
KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361
[25]   The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein [J].
Kobayashi, K ;
Sinasac, DS ;
Iijima, M ;
Boright, AP ;
Begum, L ;
Lee, JR ;
Yasuda, T ;
Ikeda, S ;
Hirano, R ;
Terazono, H ;
Crackower, MA ;
Kondo, I ;
Tsui, LC ;
Scherer, SW ;
Saheki, T .
NATURE GENETICS, 1999, 22 (02) :159-163
[26]  
KOBAYASHI K, 1991, MOL BIOL MED, V8, P95
[27]   A nonsense mutation is responsible for the RNA-negative phenotype in human citrullinaemia [J].
Li, CM ;
Cha, HK ;
Liu, YF ;
Su, TS .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (09) :685-689
[28]   LONG-TERM SURVIVAL OF PATIENTS WITH ARGININOSUCCINATE SYNTHETASE DEFICIENCY [J].
MAESTRI, NE ;
CLISSOLD, DB ;
BRUSILOW, SW .
JOURNAL OF PEDIATRICS, 1995, 127 (06) :929-935
[29]   Moderate citrullinaemia without hyperammonaemia in a child with mutated and deficient argininosuccinate synthetase [J].
Ruitenbeek, W ;
Kobayashi, K ;
Iijima, M ;
Smeitink, JAM ;
Engelke, UFH ;
De Abreu, RA ;
Kwast, HT ;
Saheki, T ;
Boelen, CA ;
De Jong, JGN ;
Wevers, RA .
ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 :102-107
[30]   Neonatal screening for citrullinaemia [J].
Sander, J ;
Jansen, N ;
Sander, S ;
Steuerwald, U ;
Das, AM ;
Scholl, S ;
Trefz, FK ;
Koch, HG ;
Häberle, J ;
Korall, H ;
Marquardt, I ;
Korenke, C .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (06) :417-420